Skip to content

Clinical trials

Completed Lupus Erythematosus, Systemic trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Status: Completed Country / region: India Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20084
20103
20113
20121
20131
20181
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma4
Anthera Pharmaceuticals3
Eli Lilly and Company2
MedImmune LLC2
Amgen1
Biocon Limited1
EMD Serono1
Human Genome Sciences Inc.1
Human Genome Sciences Inc., a GSK Company1
Nektar Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic17
Autoimmune Diseases6
Connective Tissue Diseases1
Immune System Diseases1
Lupus Nephritis1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.